Osr Holdings Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.55

+0.04 (+6.94%)

As of Feb 8, 2:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +583.6% upside

Low Target $2.62

Average Target $3.76

High Target $5.13

Current Price $0.55

Current
$0.55

Target
$3.76

$2.62 $3.76 avg $5.13

Scenario Analysis

Bear Case

$2.62

376.4%

Low target

Base Case

$3.76

+583.6%

Avg target

Bull Case

$5.13

+832.7%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$4.56

-87.9% from high

52-Week Low

$2.04

+-73.0% from low

Target vs 52W High

$3.76

-17.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%